Lamivudine transiently reduces viral load and improves liver function in liver transplant recipients with fibrosing cholestatic hepatitis.
Tillmann
Hans L
HL
Trautwein
Christian
C
Bock
C Thomas
CT
Glomb
Isabella
I
Krüger
Martin
M
Böker
Klaus H W
KH
Klempnauer
Jürgen
J
Flemming
Peer
P
Manns
Michael P
MP
D002779:Cholestasis / Q000503:physiopathology* / Q000601:surgery*; D006505:Hepatitis / Q000503:physiopathology* / Q000601:surgery*; D006801:Humans; D019259:Lamivudine / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects* / Q000503:physiopathology*; D008103:Liver Cirrhosis / Q000503:physiopathology* / Q000601:surgery*; D016031:Liver Transplantation; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology*; D019562:Viral Load
D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine